Gadolinium Clinical Trials
7 recruitingDrug
Phase 13Phase 22Not Applicable1
Showing 1–7 of 7 trials
Recruiting
Phase 2
Reducing the Incidence of Symptomatic Brain Metastases With MRI Surveillance
Brain MetastasesNonsmall Cell Lung Cancer Stage III
Wake Forest University Health Sciences60 enrolled1 locationNCT05692635
Recruiting
Phase 1
Investigation of Blood-Brain-Barrier Breakdown Using Manganese Magnetic Resonance Imaging in Drug-Resistant Epilepsy
Epilepsy
National Institute of Neurological Disorders and Stroke (NINDS)40 enrolled1 locationNCT02531880
Recruiting
Phase 1
PET/MRI, 18F-FDG PET/CT and Whole Body MRI in Finding Extramedullary Myeloid Leukemia in Patients With Newly Diagnosed Acute Myeloid Leukemia
Acute Myeloid LeukemiaAcute Promyelocytic Leukemia With PML-RARA
M.D. Anderson Cancer Center77 enrolled1 locationNCT02390635
Recruiting
Metabolic Characteristics of Brain Tumors Using Hyperpolarized Carbon-13 Magnetic Resonance Spectroscopic Imaging (MRSI)
Brain Tumor Adult
University of Texas Southwestern Medical Center25 enrolled1 locationNCT03067467
Recruiting
Phase 2
Gadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the Central Nervous System
Central Nervous System NeoplasmMetastatic Malignant Neoplasm in the BrainCranial Nerve Disorder
OHSU Knight Cancer Institute150 enrolled1 locationNCT03270059
Recruiting
Phase 1
Metabolic Imaging of the Heart Using Hyperpolarized (13C) Pyruvate Injection
HypertensionHypertrophy
Sunnybrook Health Sciences Centre112 enrolled2 locationsNCT02648009
Recruiting
Not Applicable
Validity of Parametric MRI Using VIRADS
Bladder Cancer
Assiut University58 enrolled1 locationNCT05783271